The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Open accessPublished version of a preprint
Abstract
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in the state of Maharashtra in late 2020 and spread throughout India, outcompeting pre-existing lineages including B.1.617.1 (Kappa) and B.1.1.7 (Alpha) 1 . In vitro, B.1.617.2 is sixfold less sensitive to serum neutralizing antibodies from recovered individuals, and eightfold less sensitive to vaccine-elicited antibodies, compared with wild-type Wuhan-1 bearing D614G. Serum neutralizing titres against B.1.617.2 were lower in ChAdOx1 vaccinees than in BNT162b2 vaccinees. B.1.617.2 spike pseudotyped viruses exhibited compromised sensitivity to monoclonal antibodies to the receptor-binding domain and the amino-terminal domain. B.1.617.2 demonstrated higher replication efficiency than B.1.1.7 in both airway organoid and human airway epithelial systems, associated with B.1.617.2 spike being in a predominantly cleaved state compared with B.1.1.7 spike. The B.1.617.2 spike protein was able to mediate highly efficient syncytium formation that was less sensitive to inhibition by neutralizing antibody, compared with that of wild-type spike. We also observed that B.1.617.2 had higher replication and spike-mediated entry than B.1.617.1, potentially explaining the B.1.617.2 dominance. In an analysis of more than 130 SARS-CoV-2-infected health care workers across three centres in India during a period of mixed lineage circulation, we observed reduced ChAdOx1 vaccine effectiveness against B.1.617.2 relative to non-B.1.617.2, with the caveat of possible residual confounding. Compromised vaccine efficacy against the highly fit and immune-evasive B.1.617.2 Delta variant warrants continued infection control measures in the post-vaccination era.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Neutralization of Delta variant pseudovirus was decreased relative to wild type for all subgroups (Figure 2C), as has been previously reported (Mlcochova et al., 2021; Planas et al., 2021).”
From mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant (2022) · cites this paper as Mlcochova et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era
(2019) · doi:10.1101/849372 · Cited by 16,873
IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873
A simple method of estimating 50 per cent end points
Muench, H. (1938) · Medical Entomology and Zoology · Cited by 8,376
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Yu, G., Smith, D. K., Zhu, H., Guan, Y., & Lam, T. T. (2017) · Methods in Ecology and Evolution · doi:10.1111/2041-210x.12628 · Cited by 4,823
Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15562-9 · Cited by 3,097
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Research works printed but not linked: 2
- Reed, L. J. & Muench, H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493–497 (1938).
- Papa, G. et al. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion. PLoS Pathog. 17, e1009246 (2021). · DOI · Paper page
Cited by
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Viana, R., Moyo, S., Amoako, D. G., Tegally, H., Scheepers, C., Althaus, C. L., Anyaneji, U. J., Bester, P. A., Boni, M. F., Chand, M., et al. (2022) · Nature · doi:10.1038/s41586-022-04411-y · Cited by 1,690
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Carabelli, A. M., Peacock, T. P., Thorne, L. G., Harvey, W. T., Hughes, J., COVID-19 Genomics UK Consortium, de Silva, T. I., Peacock, S. J., Barclay, W. S., de Silva, T. I., et al. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00841-7 · Cited by 1,291
Self-citationStriking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Liu, L., Iketani, S., Guo, Y., Chan, J. F.-W., Wang, M., Liu, L., Luo, Y., Chu, H., Huang, Y., Nair, M. S., et al. (2022) · Nature · doi:10.1038/s41586-021-04388-0 · Cited by 1,290
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Meng, B., Abdullahi, A., Ferreira, I. A. T. M., Goonawardane, N., Saito, A., Kimura, I., Yamasoba, D., Gerber, P. P., Fatihi, S., Rathore, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04474-x · Cited by 1,146
Self-citationBroadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Cameroni, E., Bowen, J. E., Rosen, L. E., Saliba, C., Zepeda, S. K., Culap, K., Pinto, D., VanBlargan, L. A., De Marco, A., di Iulio, J., et al. (2022) · Nature · doi:10.1038/s41586-021-04386-2 · Cited by 1,080
Self-citation
Metadata
- Authors
- Mlcochova, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Ferreira, I. A. T. M., Datir, R., Collier, D. A., Albecka, A., Singh, S., Pandey, R., Brown, J., Zhou, J., Goonawardane, N., Mishra, S., Whittaker, C., Mellan, T., Marwal, R., Datta, M., Sengupta, S., Ponnusamy, K., Radhakrishnan, V. S., Abdullahi, A., Charles, O., Chattopadhyay, P., Devi, P., Caputo, D., Peacock, T., Wattal, C., Goel, N., Satwik, A., Vaishya, R., Agarwal, M., The Indian SARS-CoV-2 Genomics Consortium (INSACOG), Chauhan, H., Dikid, T., Gogia, H., Lall, H., Verma, K., Dhar, M. S., Singh, M. K., Soni, N., Meena, N., Madan, P., Singh, P., Sharma, R., Sharma, R., Kabra, S., Kumar, S., Kumari, S., Sharma, U., Chaudhary, U., Sivasubbu, S., Scaria, V., Oberoi, J. K., Raveendran, R., Datta, S., Das, S., Maitra, A., Chinnaswamy, S., Biswas, N. K., Parida, A., Raghav, S. K., Prasad, P., Sarin, A., Mayor, S., Ramakrishnan, U., Palakodeti, D., Seshasayee, A. S. N., Thangaraj, K., Bashyam, M. D., Dalal, A., Bhat, M., Shouche, Y., Pillai, A., Abraham, P., Potdar, V. A., Cherian, S. S., Desai, A. S., Pattabiraman, C., Manjunatha, M. V., Mani, R. S., Udupi, G. A., Nandicoori, V., Tallapaka, K. B., Sowpati, D. T., The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kawabata, R., Morizako, N., Sadamasu, K., Asakura, H., Nagashima, M., Yoshimura, K., Ito, J., Kimura, I., Uriu, K., Kosugi, Y., Suganami, M., Oide, A., Yokoyama, M., Chiba, M., Saito, A., Butlertanaka, E. P., Tanaka, Y. L., Ikeda, T., Motozono, C., Nasser, H., Shimizu, R., Yuan, Y., Kitazato, K., Hasebe, H., Nakagawa, S., Wu, J., Takahashi, M., Fukuhara, T., Shimizu, K., Tsushima, K., Kubo, H., Shirakawa, K., Kazuma, Y., Nomura, R., Horisawa, Y., Takaori-Kondo, A., Tokunaga, K., Ozono, S., The CITIID-NIHR BioResource COVID-19 Collaboration, Baker, S., Dougan, G., Hess, C., Kingston, N., Lehner, P. J., Lyons, P. A., Matheson, N. J., Owehand, W. H., Saunders, C., Summers, C., Thaventhiran, J. E. D., Toshner, M., Weekes, M. P., Maxwell, P., Shaw, A., Bucke, A., Calder, J., Canna, L., Domingo, J., Elmer, A., Fuller, S., Harris, J., Hewitt, S., Kennet, J., Jose, S., Kourampa, J., Meadows, A., O’Brien, C., Price, J., Publico, C., Rastall, R., Ribeiro, C., Rowlands, J., Ruffolo, V., Tordesillas, H., Bullman, B., Dunmore, B. J., Fawke, S., Gräf, S., Hodgson, J., Huang, C., Hunter, K., Jones, E., Legchenko, E., Matara, C., Martin, J., Mescia, F., O’Donnell, C., Pointon, L., Pond, N., Shih, J., Sutcliffe, R., Tilly, T., Treacy, C., Tong, Z., Wood, J., Wylot, M., Bergamaschi, L., Betancourt, A., Bower, G., Cossetti, C., De Sa, A., Epping, M., Fawke, S., Gleadall, N., Grenfell, R., Hinch, A., Huhn, O., Jackson, S., Jarvis, I., Krishna, B., Lewis, D., Marsden, J., Nice, F., Okecha, G., Omarjee, O., Perera, M., Potts, M., Richoz, N., Romashova, V., Yarkoni, N. S., Sharma, R., Stefanucci, L., Stephens, J., Strezlecki, M., Turner, L., De Bie, E. M. D. D., Bunclark, K., Josipovic, M., Mackay, M., Rossi, S., Selvan, M., Spencer, S., Yong, C., Allison, J., Butcher, H., Caputo, D., Clapham-Riley, D., Dewhurst, E., Furlong, A., Graves, B., Gray, J., Ivers, T., Kasanicki, M., Le Gresley, E., Linger, R., Meloy, S., Muldoon, F., Ovington, N., Papadia, S., Phelan, I., Stark, H., Stirrups, K. E., Townsend, P., Walker, N., Webster, J., Scholtes, I., Hein, S., King, R., Mavousian, A., Lee, J. H., Bassi, J., Silacci-Fegni, C., Saliba, C., Pinto, D., Irie, T., Yoshida, I., Hamilton, W. L., Sato, K., Bhatt, S., Flaxman, S., James, L. C., Corti, D., Piccoli, L., Barclay, W. S., Rakshit, P., Agrawal, A., & Gupta, R. K.
- Affiliations
- University of Cambridge (GB)
- MRC Laboratory of Molecular Biology (GB)
- National Center for Disease Control (IN)
- Institute of Genomics and Integrative Biology (IN)
- Imperial College London (GB)
- University College London (GB)
- Sir Ganga Ram Hospital (IN)
- Indraprastha Apollo Hospitals (IN)
- National Institute of Biomedical Genomics (IN)
- Institute of Life Sciences (IN)
- National Centre for Biological Sciences (IN)
- Centre for DNA Fingerprinting and Diagnostics (IN)
- National Centre for Cell Science (IN)
- ICMR-National Institute of Virology (IN)
- National Institute of Mental Health and Neurosciences (IN)
- Centre for Cellular and Molecular Biology (IN)
- Hiroshima University (JP)
- Tokyo Metropolitan Institute of Public Health (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- University of Miyazaki (JP)
- Kumamoto University (JP)
- Tokai University (JP)
- Hokkaido University (JP)
- Kyoto University (JP)
- National Institute of Infectious Diseases (JP)
- NIHR BioResource (GB)
- Africa Health Research Institute (ZA)
- University of Oxford (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Vir Biotechnology (Switzerland) (CH)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Japan Science and Technology Agency (JP)
- Corresponding author
- Rakshit, Partha
- Agrawal, Anurag
- Gupta, Ravindra K.
- ORCID
- Kemp, Steven A.
- Papa, Guido
- Meng, Bo
- Ferreira, Isabella A. T. M.
- Datir, Rawlings
- Collier, Dami A.
- Albecka, Anna
- Singh, Sujeet
- Pandey, Rajesh
- Brown, Jonathan
- Zhou, Jie
- Goonawardane, Niluka
- Mishra, Swapnil
- Whittaker, Charles
- Mellan, Thomas
- Marwal, Robin
- Sengupta, Shantanu
- Ponnusamy, Kalaiarasan
- Radhakrishnan, Venkatraman Srinivasan
- Abdullahi, Adam
- Charles, Oscar
- Chattopadhyay, Partha
- Devi, Priti
- Wattal, Chand
- Goel, Neeraj
- Vaishya, Raju
- Agarwal, Meenakshi
- Chauhan, Himanshu
- Dikid, Tanzin
- Lall, Hemlata
- Singh, Manoj K.
- Madan, Preeti
- Singh, Priyanka
- Sharma, Rajeev
- Kumari, Swati
- Sharma, Uma
- Chaudhary, Urmila
- Sivasubbu, Sridhar
- Scaria, Vinod
- Oberoi, J. K.
- Das, Saumitra
- Maitra, Arindam
- Chinnaswamy, Sreedhar
- Biswas, Nidhan Kumar
- Parida, Ajay
- Raghav, Sunil K.
- Prasad, Punit
- Sarin, Apurva
- Mayor, Satyajit
- Ramakrishnan, Uma
- Palakodeti, Dasaradhi
- Seshasayee, Aswin Sai Narain
- Bashyam, Murali Dharan
- Dalal, Ashwin
- Shouche, Yogesh
- Pillai, Ajay
- Abraham, Priya
- Potdar, Varsha Atul
- Cherian, Sarah S.
- Desai, Anita Sudhir
- Pattabiraman, Chitra
- Mani, Reeta S.
- Nandicoori, Vinay
- Tallapaka, Karthik Bharadwaj
- Sowpati, Divya Tej
- Sadamasu, Kenji
- Asakura, Hiroyuki
- Nagashima, Mami
- Yoshimura, Kazuhisa
- Ito, Jumpei
- Saito, Akatsuki
- Butlertanaka, Erika P.
- Tanaka, Yuri L.
- Ikeda, Terumasa
- Motozono, Chihiro
- Nasser, Hesham
- Yuan, Yue
- Nakagawa, So
- Wu, Jiaqi
- Fukuhara, Takasuke
- Shimizu, Kenta
- Shirakawa, Kotaro
- Kazuma, Yasuhiro
- Nomura, Ryosuke
- Tokunaga, Kenzo
- Ozono, Seiya
- Baker, Stephen
- Dougan, Gordon
- Hess, Christoph
- Kingston, Nathalie
- Lehner, Paul J.
- Lyons, Paul A.
- Matheson, Nicholas J.
- Summers, Charlotte
- Thaventhiran, James E. D.
- Toshner, Mark
- Weekes, Michael P.
- Maxwell, Patrick
- Shaw, Ashley
- Domingo, Jason
- Kennet, Jane
- Price, Jane
- Rowlands, Jane
- Dunmore, Benjamin J.
- Gräf, Stefan
- Legchenko, Ekaterina
- Martin, Jennifer
- Mescia, Federica
- Pointon, Linda
- Sutcliffe, Rachel
- Tilly, Tobias
- Bergamaschi, Laura
- Cossetti, Chiara
- Epping, Madeline
- Grenfell, Richard
- Jackson, Sarah
- Nice, Francesca
- Omarjee, Ommar
- Perera, Marianne
- Potts, Martin
- Richoz, Nathan
- Yarkoni, Natalia Savinykh
- Sharma, Rahul
- Stefanucci, Luca
- Stephens, Jonathan
- Bunclark, Katherine
- Rossi, Sabrina
- Yong, Cissy
- Papadia, Sofia
- Stark, Hannah
- Stirrups, Kathleen E.
- Walker, Neil
- Webster, Jennifer
- King, Rebecca
- Mavousian, Antranik
- Bassi, Jessica
- Saliba, Christian
- Pinto, Dora
- Irie, Takashi
- Yoshida, Isao
- Sato, Kei
- Bhatt, Samir
- Flaxman, Seth
- James, Leo C.
- Corti, Davide
- Piccoli, Luca
- Rakshit, Partha
- Agrawal, Anurag
- Gupta, Ravindra K.
- Venue
- Nature
- Published
- 2021-09-06
- Volume
- 599
- Issue
- 7883
- Pages
- 114-119
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC8566220
- OpenAlex
- W3198233589
- Cited by
- 1,337
- References
- 67
- Citations by year
- 2026: 46 · 2025: 92 · 2024: 147 · 2023: 281 · 2022: 614 · 2021: 155
- FWCI
- 95.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo
- Greater South Information System
- Funders
- Bill and Melinda Gates Foundation (OPP 1175094)
- Japan Agency for Medical Research and Development (CREST, 20fk0108413h0001)
- Wellcome Trust (108070/Z/15/Z, 108082/A/15/Z, 108082, WT108082AIA, MR/W005611/1, DEL-15-006, 200594/Z/16/Z, 081772)
- UK Research and Innovation (MR/W005611/1/)
- Cancer Research UK (22310)
- National Institute for Health and Care Research (OPP1175094, DEL-15-006)
- Academy of Medical Sciences (SBF004\1080)
- Rosetrees Trust
- Evelyn Trust (20/75)
- NIHR BioResource
- Medical Research Council (MC_PC_17230, MR/R015600/1, MR/W005611/1, MC_PC_19012, COVID-19)
- Engineering and Physical Sciences Research Council (EP/V002910/1, EP/V002910/2, MR/W005611/1)
- Japan Society for the Promotion of Science (18H02662, 19K22968, 18KK0447, 21K07060)
- Addenbrooke's Charitable Trust, Cambridge University Hospitals (900275 Minute 47/20B)
- Core Research for Evolutional Science and Technology (JPMJCR20H4)
- Strategic International Collaborative Research Program
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- Delta variant, immune evasion, neutralizing antibodies, spike protein cleavage, syncytium formation, ChAdOx1 nCoV-19 vaccine, BNT162b2, vaccine effectiveness, receptor binding domain, N-terminal domain, airway organoids, healthcare workers, D614G
- MeSH terms
- SARS-CoV-2, COVID-19 Vaccines, Cell Fusion, Cell Line, Female, Health Personnel, Humans, India, Kinetics, Male, Vaccination, Virus Replication, Immune Evasion, Antibodies, Neutralizing, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. https://app.cochat.ai/papers/10.1038/s41586-021-03944-y
- The paper
- Mlcochova, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Ferreira, I. A. T. M., Datir, R., Collier, D. A., Albecka, A., Singh, S., Pandey, R., Brown, J., Zhou, J., Goonawardane, N., Mishra, S., Whittaker, C., Mellan, T., Marwal, R., Datta, M., . . . Gupta, R. K. (2021). SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature. https://doi.org/10.1038/s41586-021-03944-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.